Back to search
FDAFDA · Food and drugs·Recall number D-0242-2021

Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40

Published February 3, 2021 · Recall initiated: January 11, 2021

Summary

FDA records drug Class III recall D-0242-2021, published February 3, 2021 and initiated January 11, 2021. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: 36,275 cartons; Lot: Lot JKX2553A. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect Labeling: Incorrect lot number on secondary packaging

What to do

Voluntary: Firm initiated · Letter

Get an email if TESTOSTERONE CYPIONATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TESTOSTERONE CYPIONATE
Manufacturer
SUN PHARMACEUTICAL INDUSTRIES INC
Distributor
Nationwide
UPC
0362756017405
Lot
Lot JKX2553A
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40 recalled?

Yes. FDA published recall D-0242-2021 on February 3, 2021. Reported hazard: Incorrect Labeling: Incorrect lot number on secondary packaging

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TESTOSTERONE CYPIONATE. UPC: 0362756017405.